Polar Capital Biotech I Inc GBP (FUND:B42P0H7) - Fund price - Overview


Fund Report

Polar Capital Funds PLC - Biotechnology Fund I Inc (GBP)

Key Stats
Morningstar® CategorySector Equity Biotechnology
Manager Name-
Inception Date31/10/2013
NAV 17/04/2019GBP 18.21
Day Change-3.96%
12 Month Yield-
ISINIE00B42P0H75
SEDOLB42P0H7
Dividend FrequencyAnnually
Net Assets (mil) 28/02/2019514.31 USD
Wrapper AvailabilityAll
Our Minimum Initial Investment1.00 Share
Pricing FrequencyDaily
Dealing Cut off Time15:00:00
Regular InvestmentNo
Actual Initial Charge-
Exit Charge-
Custody ChargeYes
Ongoing Cost1.16%
AMC1.00%
Fund Rebate-

Morningstar Rating™

5 Stars

Morningstar Sustainability Rating

Below Average

Below Average


Sustainability Rating as of 28/02/2019

Benchmarks

Fund Benchmark

NASDAQ Biotechnology TR USD

Morningstar® Benchmark

MSCI World/Biotechnology NR USD

Growth Of 10,000 (GBP) 31/03/2019

How has this security performed
201420152016201720182019
Fund57.8419.4810.3319.462.0816.20
Category38.5413.41-3.9610.29-7.9613.94
Benchmark38.9313.904.787.961.671.18
  • Fund: Polar Capital Funds PLC - Biotechnology Fund I Inc (GBP)
  • Category: Sector Equity Biotechnology
  • Benchmark: MSCI World/Biotechnology NR USD
Trailing Returns % (GBP) 17/04/2019
FundCatBmark
YTD9.2410.32-4.00
3 Years Annualised17.457.205.21
5 Years Annualised21.0711.6412.75
10 Years Annualised---

Morningstar SRRI

Lower Risk
Higher Risk
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
Potentially Lower ReturnsPotentially Higher Returns
Source: Morningstar

Investment Objective

The investment objective of the Fund is to preserve capital and achieve long term capital appreciation.

Portfolio Profile28/02/2019

Morningstar Style Box®

Equity Style

Large, Mid, SmallSize
Value, Blend, Growth
Style
Top Holdings
NameSector%
IncreaseDecreaseNew since last portfolio
IncreaseAlexion Pharmaceuticals Inc Healthcare7.89
New since last portfolioRegeneron Pharmaceuticals Inc Healthcare6.70
Incyte Corp Healthcare6.20
argenx SE Healthcare5.82
IncreaseVertex Pharmaceuticals Inc Healthcare5.50
Asset Allocation %
LongShortNet
Stocks89.840.0089.84
Bonds0.000.000.00
Cash10.160.0010.16
Other0.000.000.00
Top Stock Regions
Region%
United States64.34
Eurozone16.63
Europe - ex Euro6.69
Asia - Emerging5.40
United Kingdom3.45
Top Stock Sectors
Stock Sector%
Healthcare100.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.